BAY1125976, CAS 1402608-02-9

BAY1125976, CAS 1402608-02-9
Artikelnummer
MEXHY-100018-25
Verpackungseinheit
25 mg
Hersteller
MedChemExpress

Verfügbarkeit: wird geladen...
Preis wird geladen...
Product Description: BAY1125976 is a selective allosteric Akt1/Akt2 inhibitor; inhibits Akt1 and Akt2 activity with IC50 values of 5.2 nM and 18 nM at 10 μM ATP, respectively.

Applications: Cancer-Kinase/protease

Formula: C23H21N5O

References: [1]Politz O, et al. BAY 1125976, a selective allosteric AKT1/2 inhibitor, exhibits high efficacy on AKT signaling-dependent tumor growth in mouse models. Int J Cancer. 2017 Jan 15;140(2):449-459.

CAS Number: 1402608-02-9

Molecular Weight: 383.45

Compound Purity: 99.52

Research Area: Cancer

Solubility: DMSO : 25 mg/mL (ultrasonic)

Target: Akt
Mehr Informationen
Artikelnummer MEXHY-100018-25
Hersteller MedChemExpress
Hersteller Artikelnummer HY-100018-25
Verpackungseinheit 25 mg
Mengeneinheit STK
Produktinformation (PDF)
×
MSDS (PDF)
×